Related Experiment Video
Updated: Jan 26, 2026

Microscopic Cyst Resection for the Treatment of Patients Diagnosed with Epididymal Cyst
Published on: March 31, 2023
Cyclooxygenase-2 and Cytosolic Phospholipase A2 Are Overexpressed in Mucinous Pancreatic Cysts
Elsie T Mensah1, Thomas Smyrk2, Lizhi Zhang2
1Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Objectives:
Expression of prostaglandin biosynthetic pathway enzymes in mucinous pancreatic cysts is unknown. Cyclooxygenase-2 (COX-2) inhibition is a potential cancer chemoprevention strategy for these lesions. We evaluated the expression of COX-2, cytosolic phospholipase A2 (cPLA2), and protein kinase B (AKT) in the epithelium of pancreatic cysts and correlated enzyme expression with aspirin (ASA) use and cyst fluid prostaglandin E2 (PGE2) concentration.
Methods:
Pathology of 80 resected pancreatic cysts was reviewed. Expression of COX-2, cPLA2, and AKT was quantified by tissue immunohistochemistry immunoreactivity scores (IRSs). IRS values were compared between cyst types and (in 30 cases) with matched cyst fluid PGE2 concentrations.
Results:
The mean IRS was higher in the epithelium of mucinous vs nonmucinous cysts for COX-2 (6.1 ± 4.7 vs 3.2 ± 2.8, P = 0.01) and cPLA2 (6.9 ± 3.0 vs 2.9 ± 2.9, P < 0.001). Cyst epithelial COX-2 expression was higher in mucinous cysts with low-grade dysplasia vs those with high-grade dysplasia or invasive carcinoma (IRS 8.0 ± 3.9 vs 1.5 ± 2.9, P < 0.001), whereas the opposite was found for cPLA2 (6.2 ± 3.0 vs 8.6 ± 2.3, P = 0.005). Cyst fluid PGE2 concentrations did not correlate with either the IRS or a history of low- to moderate-dose ASA use.
Conclusions:
COX-2 and cPLA2 are overexpressed in the epithelium of mucinous pancreatic cysts. COX-2 and/or cPLA2 inhibition might prevent the emergence or progression of mucinous pancreatic cysts, but higher doses of ASA or nonsteroidal anti-inflammatory drugs may be necessary to substantially inhibit cyst epithelial COX-2 activity.
Insights
Cyclooxygenase-2 (COX-2) and cytosolic phospholipase A2 (cPLA2) are overexpressed in mucinous pancreatic cysts. Their inhibition may prevent cyst progression, potentially requiring higher aspirin (ASA) doses.
Area of Science:
- Gastroenterology
- Oncology
- Biochemistry
Background:
- The expression of enzymes in the prostaglandin biosynthetic pathway within mucinous pancreatic cysts is not well understood.
- Cyclooxygenase-2 (COX-2) inhibition presents a potential strategy for cancer chemoprevention in these lesions.
Purpose of the Study:
- To evaluate the expression of COX-2, cytosolic phospholipase A2 (cPLA2), and protein kinase B (AKT) in pancreatic cyst epithelium.
- To correlate enzyme expression with aspirin (ASA) use and cyst fluid prostaglandin E2 (PGE2) levels.
Main Methods:
- Review of pathology from 80 resected pancreatic cysts.
- Quantification of COX-2, cPLA2, and AKT expression using immunohistochemistry immunoreactivity scores (IRSs).
- Comparison of IRS values between cyst types and with cyst fluid PGE2 concentrations.
Main Results:
- Mucinous cysts showed significantly higher COX-2 and cPLA2 expression compared to nonmucinous cysts.
- COX-2 expression was higher in low-grade dysplasia mucinous cysts, while cPLA2 was higher in high-grade dysplasia or invasive carcinoma.
- Cyst fluid PGE2 levels did not correlate with enzyme expression or low- to moderate-dose ASA use.
Conclusions:
- COX-2 and cPLA2 are overexpressed in mucinous pancreatic cysts.
- Inhibition of COX-2 and/or cPLA2 may prevent the development or progression of these cysts.
- Higher doses of aspirin or NSAIDs might be needed to effectively inhibit cyst epithelial COX-2 activity.
Related Concept Videos
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
2° Amines to N-Nitrosamines: Reaction with NaNO2
Chronic Pancreatitis II: Collaborative Care
Assessment:

